Trial Profile
Behavior rating inventory of executive function-adult version (BRIEF-A) effects with atomoxtine.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jul 2011
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors Lilly Research Centre
- 27 Jul 2011 New trial record
- 18 May 2011 Results presented at the 164th Annual Meeting of the American Psychiatric Association.